140 related articles for article (PubMed ID: 2807780)
1. The Nd:YAG laser and methylene blue staining in the diagnosis and treatment of premalignant vesical lesions and carcinoma in situ (CIS).
Gaboardi F; Bordinazzo R; Galli L
Int Urol Nephrol; 1989; 21(3):289-97. PubMed ID: 2807780
[TBL] [Abstract][Full Text] [Related]
2. [Chromocystoscopy using methylene blue in the early diagnosis of tumors of the bladder and of precancerous lesions].
Galli L; Gaboardi F
Arch Esp Urol; 1985; 38(4):347-51. PubMed ID: 2416276
[No Abstract] [Full Text] [Related]
3. Fluorescence cystoscopy in the diagnostics and treatment of bladder tumors.
Petrík R; Jirsa M; Dvorák E; Skoda V; Stádník B
Biomed Tech (Berl); 1998; 43 Suppl():74-5. PubMed ID: 9859264
[No Abstract] [Full Text] [Related]
4. Is there a role for in vivo methylene blue staining in the prediction of bladder tumour recurrence?
Creagh TA; Gleeson M; Travis D; Grainger R; McDermott TE; Butler MR
Br J Urol; 1995 Apr; 75(4):477-9. PubMed ID: 7788259
[TBL] [Abstract][Full Text] [Related]
5. Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder.
Vicente J; Chéchile G; Algaba F
Eur Urol; 1987; 13(1-2):15-6. PubMed ID: 2438139
[TBL] [Abstract][Full Text] [Related]
6. Selective surface staining of bladder tumors by intravesical methylene blue with enhanced endoscopic identification.
Gill WB; Huffman JL; Lyon ES; Bagley DH; Schoenberg HW; Straus FH
Cancer; 1984 Jun; 53(12):2724-7. PubMed ID: 6202385
[TBL] [Abstract][Full Text] [Related]
7. [Staining test with methylene blue during resection of bladder cancer in 30 patients].
Jia WY; Li WL; Chen HG
Zhonghua Wai Ke Za Zhi; 1994 Jun; 32(6):351-3. PubMed ID: 7531137
[TBL] [Abstract][Full Text] [Related]
8. In vivo staining test with methylene blue for bladder cancer.
Fukui I; Yokokawa M; Mitani G; Ohwada F; Wakui M; Washizuka M; Tohma T; Igarashi K; Yamada T
J Urol; 1983 Aug; 130(2):252-5. PubMed ID: 6192250
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence imaging of bladder cancer.
D'Hallewin MA; Baert L; Vanherzeele H
Acta Urol Belg; 1994 Dec; 62(4):49-52. PubMed ID: 7793348
[TBL] [Abstract][Full Text] [Related]
10. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG
Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972
[TBL] [Abstract][Full Text] [Related]
11. Laser management of premalignant lesions of the larynx.
Strong MS
Can J Otolaryngol; 1974; 3(4):560-3. PubMed ID: 4473258
[No Abstract] [Full Text] [Related]
12. Long-term follow-up results of Nd: YAG laser treatment of premalignant and malignant (Stage I) squamous cell carcinoma of the oral cavity.
Tewari M; Rai P; Singh GB; Kumar M; Shukla HS
J Surg Oncol; 2007 Mar; 95(4):281-5. PubMed ID: 17326123
[TBL] [Abstract][Full Text] [Related]
13. Intravesical therapy with adriamycin in urothelial dysplasia and early carcinoma in situ.
Glashan RW; Riley A
Can J Surg; 1982 Jan; 25(1):30-2. PubMed ID: 7055761
[TBL] [Abstract][Full Text] [Related]
14. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
Bach T; Bastian PJ; Blana A; Kaminsky A; Keller S; Knoll T; Lang C; Promnitz S; Ubrig B; Keller T; Qvick B; Burger M;
World J Urol; 2017 May; 35(5):737-744. PubMed ID: 27578233
[TBL] [Abstract][Full Text] [Related]
15. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
16. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions.
Zaak D; Hungerhuber E; Schneede P; Stepp H; Frimberger D; Corvin S; Schmeller N; Kriegmair M; Hofstetter A; Knuechel R
Cancer; 2002 Sep; 95(6):1234-8. PubMed ID: 12216090
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing the location of carcinoma in situ (CIS) of the urinary bladder using pirarubicin hydrochloride.
Uchikoba T; Horiuchi K; Oka F; Sato M; Tsuboi N; Ohaki Y; Nishimura T
Urol Int; 2005; 74(3):235-9. PubMed ID: 15812210
[TBL] [Abstract][Full Text] [Related]
18. Value of random endoscopic biopsy in the diagnosis of bladder carcinoma in situ.
Vicente-Rodriguez J; Chéchile G; Algaba F; Amaral J
Eur Urol; 1987; 13(3):150-2. PubMed ID: 3609088
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer.
Trott PA; Edwards L
J Urol; 1973 Dec; 110(6):664-6. PubMed ID: 4757548
[No Abstract] [Full Text] [Related]
20. [Urothelial lesions associated with bladder carcinoma. Histological study of 18 radical cystectomy specimens].
Carrillo G; Nappi O; Iacobelli P
Pathologica; 1981; 73(1026):589-96. PubMed ID: 7312432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
